Health Care Investment Banking Group

What we can do for you

Health care in the US is undergoing a fundamental transformation — the move to “Health 2.0,” the consumer-centric, outcomes-driven, prevention-focused future of health care. This tectonic shift is driving significant consolidation and convergence as providers and payers across the health care ecosystem look to improve quality, reduce costs, and improve population health.

Our EYCA Health Care practice has a proud tradition and strong track record of successfully advising health care organizations and investors as they navigate the increasingly challenging health care landscape. We advise clients on their strategic and transaction alternatives.

Our health care investment banking team provides clients with a broad range strategy and transactions, including mergers & acquisitions advisory; strategic business review & development; corporate finance analyses; corporate divestiture advisory; and debt & equity capital raising advisory.

Our professionals have deep sector knowledge built over years of focused industry coverage and our team focuses exclusively on its health care services clients. We work collaboratively with a wide range of organizations, including private for-profit companies; publicly traded companies; and not-for-profit entities.

Our team focuses our industry coverage across seven primary sectors: Health Care Services; Managed Care; Health Care IT; Pharma Services/Distribution; Therapeutics; Tools & Diagnostics; and Medical Technology.

Within those primary sectors, our team has experience advising clients across a diverse range of health care subverticals, including:

Health Care Services
  • Acute care
  • Alternate site services
  • Ambulatory surgery centers
  • Behavioral health
  • Clinical/hospital outsourcing
  • Dental Services
  • Diagnostic services
  • Dialysis
  • Home health and hospice
  • Long-term care
  • Physician services
  • Rehabilitation/physical therapy
  • Urgent care
Managed Care
  • ACO solutions
  • Care/disease management
  • Consumer-directed health care
  • Managed care organizations
  • Pharmacy benefit managers
  • Population health
  • Specialty benefit managers
  • Workers’ compensation
Health Care IT
  • Ambulatory solutions
  • Clinical management
  • Data/predictive analytics
  • Enterprise solutions
  • Mobile health
  • Payor solutions
  • Population health
  • Revenue cycle management
  • Telemedicine
Pharma Services/Distribution
  • Alternate site distribution
  • Compounding pharmacy
  • CROs/IRBs
  • Drug distribution
  • Institutional pharmacy
  • Medical-surgical distribution
  • Retail pharmacy
  • Specialty pharmacy
  • Biosimilars
  • Biotechnology
  • Branded pharmaceuticals
  • Contract manufacturing organizations
  • Generic pharmaceuticals
  • Specialty pharmaceuticals
Tools & Diagnostics
  • Genetic sequencing
  • Laboratories
Medical Technology
  • Cardiovascular
  • CNS
  • Diabetes
  • Ophthalmology
  • Orthopedics

Representative transactions

Our team

Slava Girzhel

US Head of Health Care Investment Banking and Senior Managing Director, Ernst & Young Capital Advisors, LLC

Health care investment banker. M&A and capital markets transactions advisory professional. Strategic advisor. Father. Avid traveler.

Cleveland, USA

Karan Jolly

Managing Director, US Health Care Investment Banking, Ernst & Young Capital Advisors, LLC

Health care technology-focused investment banker. Seasoned M&A professional. Trusted advisor. Proud girl dad.

Cleveland, USA

Jeff McMahon

Ernst & Young Capital Advisors, LLC US Health Care Investment Banking, Managing Director

Seasoned M&A and strategy professional. Health care specialist. Trusted C-suite advisor. College football fan. Proud father.

New York, USA

Kurtis Parker

Managing Director, US Health Care Investment Banking, Ernst & Young Capital Advisors, LLC

MedTech and diagnostics-focused investment banker advising on M&A and capital markets transactions. My wife and I have five children and live in Nashville, TN.

Nashville, USA

Yasir Agha

Senior Vice President, US Health Care Investment Banking, Ernst & Young Capital Advisors, LLC

M&A and capital markets transaction advisor focused on health care. Avid reader and traveler.

New York, USA

Doug Fullerton

Senior Vice President, US Health Care Investment Banking, Ernst & Young Capital Advisors, LLC

Health care investment banker. M&A and capital markets transaction advisory professional. Amateur golfer in search of past glory. Nashvillian expatriate.

New York, USA

Our latest thinking

CEO Survey: Focus on GenAI strategy to accelerate growth

Our survey finds US CEOs preparing for a new normal of costly capital while M&A intentions remain strong and divestment plans are robust.

30 Oct 2023 EY Americas

The new corporate strategy playing field

Corporate strategy is being upended by new stakeholders, competitors and the need to quickly add differentiating capabilities.

05 Oct 2022 Chris Librizzi + 1

    Contact us
    Like what you’ve seen? Get in touch to learn more.

    Check the background of this firm or its investment professionals at FINRA’s BrokerCheck.

    Ernst & Young Capital Advisors, LLC (EYCA) is a registered broker-dealer and member of FINRA providing sector-specific advice on M&A, debt capital markets, equity capital markets and capital restructuring transactions. It is an affiliate of Ernst & Young LLP serving clients in the US.